12‐HETE is an Endogenous Modulator of BLT2 Triggering Vascular Degeneration, Dissection, and Rupture
Advanced Science · 2026
DOI: 10.1002/advs.202515897 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Yuyu Li und 13 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Anzhen Hospital, Capital Medical University, Key Laboratory of Remodeling-related Cardiovascular Diseases, Ministry of Education, Beijing Col…. Hauptthemen laut MEDLINE: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid, Receptors, Leukotriene B4, Aortic Dissection. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
Thoracic aortic dissection (TAD), a life‐threatening vascular emergency requiring urgent pharmacological intervention, prompted investigation into arachidonic acid metabolites based on their established roles in inflammation and vascular homeostasis. Through comprehensive plasma metabolomics analysis performed in both TAD patients and a β‐aminopropionitrile monofumarate (BAPN)‐induced mouse model, significant elevation of 12‐hydroxyeicosatetraenoic acid (12‐HETE) was identified, accompanied by marked upregulation of its synthetic enzyme 12/15‐lipoxygenase (12/15‐LOX) in dissected aortic tissues. The pathogenetic significance was further demonstrated by the substantial protection against TAD progression that was observed in Alox15‐deficient mice. Mechanistically, 12‐HETE was confirmed to function as an endogenous ligand for the BLT2 receptor on macrophages, leading to activation of the NOX‐1/ROS/NF‐κB signaling cascade. This signaling activation was shown to induce inflammatory cytokine release and promote inflammatory cell recruitment, ultimately resulting in pathological phenotype switching of vascular smooth muscle cells. The therapeutic potential was validated by significant reduction in dissection rupture rates that was achieved with either the 12/15‐LOX inhibitor ML351 or the BLT2 antagonist LY255283, with maximal efficacy being demonstrated when both agents were administered in combination. These findings establish the 12‐HETE‐BLT2 axis as a key driver of TAD pathogenesis and validate its potential as a promising therapeutic target for clinical intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Beijing Anzhen Hospital, Capital Medical University, Key Laboratory of Remodeling-related Cardiovascular Diseases, Ministry of Education, Beijing Collaborative Innovation Centre for Cardiovascular Disorders, No. 2 Anzhe…
- Beijing Institute of Heart, Lung and Blood Vessel Disease, No. 2 Anzhen Road, Chaoyang District, Beijing, 100029, China.
- Department of Cardiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou Medical University, Wenzhou, Zhejiang, 325015, China.
- Department of Cardiology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou Medical University, Wenzhou, Zhejiang, 325027, China.
- Department of Nutrition, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, 510080, China.
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Li, Y., Yu, J., Chen, W., Wang, X., Tan, X., Cui, J., Wang, Y., Xu, X., Lin, R., Wang, Z., Jiang, W., Zhong, Y., Du, J., & Wang, Y. (2026). 12‐HETE is an Endogenous Modulator of BLT2 Triggering Vascular Degeneration, Dissection, and Rupture. Advanced Science. https://doi.org/10.1002/advs.202515897
Vancouver
Li Y, Yu J, Chen W, Wang X, Tan X, Cui J, et al. 12‐HETE is an Endogenous Modulator of BLT2 Triggering Vascular Degeneration, Dissection, and Rupture. Advanced Science. 2026. doi:10.1002/advs.202515897
BibTeX
@article{Li2026,
author = {Li, Yuyu and Yu, Jiaqi and Chen, Weiyao and Wang, Xue and Tan, Xin and Cui, Jing and Wang, Yihao and Xu, Xuan and Lin, Rui and Wang, Zhengkai and Jiang, Wenxi and Zhong, Yongliang and Du, Jie and Wang, Yuan},
title = {12‐HETE is an Endogenous Modulator of BLT2 Triggering Vascular Degeneration, Dissection, and Rupture},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202515897}
}
EUVIMED